RECRUITMENT AND EDUCATION CORE

研究阿尔茨海默病（AD）的新药物和诊断是至关重要的，需要大量的患者和正常对照个体。这种“治疗的必要性”是加州大学洛杉矶分校阿尔茨海默病研究中心（ADRC）的主题。招募参与者，在研究项目期间保留受试者，以及保证代表较大疾病人群的研究人群是UCLA ADRC招募和教育核心（REC）的目标。区域经济委员会已获得大量资源，使实现这些目标成为现实。REC将参与各种独特和创新的招聘，保留，社区推广和教育战略。REC赞助了各种教育会议，其中许多是与阿尔茨海默氏症协会等社区组织合作完成的。反歧视研究的一个明显需要是增加少数群体的代表性。在上一个赠款周期，REC达到20，000教育活动的参与者，包括1000名临床医生和900多名少数民族 社区成员。区域环境中心在新的赠款周期有一系列面向少数群体的强有力的活动。新的这一建议，REC将发展非洲裔美国人和西班牙裔社区咨询委员会，以指导少数民族的招聘工作。REC还将与医疗保健传播集团合作，提高公众对AD研究的认识，并与PriMed研究所合作，教育初级保健医生了解AD管理指南和增加研究转诊的必要性。区域经济委员会将继续与亚洲发展与改革委员会的其他核心密切合作。这包括与数据管理和统计核心的合作，以更好地估计所需的研究对象的数量;与临床核心，以确保为统一数据集（UDS）正确收集数据;与神经病理学核心进行成功的临床病理学会议（CPC）;并与管理核心一起确保中心网站和其他工具的最大功能，以使受试者、捐赠者和一般社区了解中心的活动。所有REC活动都将持续进行成功评估。这包括不断监测入组研究受试者的来源。评估将决定未来的方案和资源使用。

Research investigating new medications and diagnostics for Alzheimer's disease (AD) is critical and will require large numbers of patients and normal control individuals. This "therapeutic imperative" is the theme of the Alzheimer Disease Research Center (ADRC) at UCLA. Recruitment of participants, retention of subjects for the duration of research projects, and the assurance of research populations that are representative of the larger disease population are the objectives of the Recruitment and Education Core (REC) at the UCLA ADRC. The REC has been infused with substantial resources to make accomplishment of these objectives realistic. The REC will engage in a wide number of unique and innovative recruitment, retention, community outreach, and educational strategies. The REC sponsors a variety of educational conferences, many of which are done in partnership with community organizations such as the Alzheimer's Association. A clear need in AD research is to increase representation of minorities. In the last grant cycle, REC reached 20,000 educational event attendees, including 1000 clinicians and over 900 minority community members. REC has a robust array of minority-oriented activities for the new grant cycle. New to this proposal, the REC will develop of African American and Hispanic Community Advisory Boards to guide minority recruitment efforts. The REC will also partner with Healthcare Communications Group to increase public awareness of AD research, and with the PriMed Institute to educate primary care physicians on AD management guidelines and the need for increased referrals to research. The REC will continue to work closely with the other Cores of the ADRC. This includes collaborations with the Data Management and Statistics Core to better estimate the number of needed research subjects; with the Clinical Core to ensure the proper collection of data for the Uniform Data Set (UDS); with the Neuropathology Core to conduct the successful ClinicoPathologic Conference (CPC); and with Administrative Core to ensure the maximal functionality of the Center website and other tools to keep subjects, donors, and the general community aware of the Center's activities. All REC activities will be continually evaluated for success. This includes a constant monitoring of the sources of enrolled research subjects. Evaluations will dictate future programs and resource use.